Update: Characteristics of Patients in a National Outbreak of E-Cigarette, or Vaping, Product Use-Associated Lung Injuries – United States, October 2019

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Annor, Francis B. ; Briss, Peter A. ; Chatham-Stephens, Kevin ; Delaney, Lisa J. ; DeSisto, Carla L. ; Garcia, Macarena C. ; Glidden, Emily ; Hughes, Michelle M. ; Jones, Christopher M. ; Kenemer, Brandon ; Kimball, Anne A. ; King, Brian A. ; Koumans, Emily H. ; Lekiachvili, Akaki ; Meaney-Delman, Dana ; Moritz, Erin D. ; Patel, Anita ; Petersen, Emily E. ; Polen, Kara D. ; Reagan-Steiner, Sarah ; Ritchey, Matthew D. ; Shamout, Mays ; Sives, Katie ; Ussery, Emily N. ; Werner, Angela K. ; Zapata, Lauren B.
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  What is already known about this topic? CDC and partners are investigating the ongoing outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) in the United States, the District of Columbia, and one U.S. territory. What is added by this report? As of October 22, 2019, a total of 1,604 cases of EVALI, including 34 deaths, were reported to CDC. Based on data collected as of October 15, 2019, use of tetrahydrocannabinol (THC)-containing products in the 3 months preceding symptom onset was reported by 86% of patients. The median age of EVALI patients who survived was 23 years, and the median age of EVALI patients who died was 45 years. What are the implications for public health practice? Most EVALI patients report using THC-containing products before symptom onset. CDC recommends that persons should not use e-cigarette, or vaping, products containing THC. Because the specific compound or ingredient causing EVALI is not known, persons should consider refraining from use of all e-cigarette, or vaping, products. Erratum: MMWR 2019 Dec 20; 68(50);1170 the list of contributors on the Lung Injury Response Epidemiology/Surveillance Task Force should have included Samantha J. Lange, National Center for Chronic Disease Prevention and Health Promotion, CDC. [Description provided by NIOSH]
• Subjects:
  Electrical Equipment And Supplies Hazardous Substances Lung Lung Diseases Mortality Nicotine Occupational Health Public Health Respiratory System Respiratory Tract Diseases Safety Smokers Solvents Tobacco Products

  More +
• Keywords:
  Age Groups Case Reports Chemical Hazards Cigarette Smoking Disease Incidence Electronic Devices Fatalities Hazardous Drugs Health Effects Health Protection Humans Lung Disease Lung Disorders Mortality Data Partnership Psychotropic Drugs Public Health Pulmonary Disorders Pulmonary Effects Pulmonary System Disorders Recommendations Safety Education Surveillance Survival Rate Tobacco Vapors

  More +
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Publisher:
  Centers for Disease Control and Prevention (CDC) (U.S.)
• Document Type:
  Text
• Funding:
  Cooperative Agreement
• Genre:
  Journal Article
• Place as Subject:
  United States
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  OD - Office of the Director
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  5 pdf pages
• Volume:
  68
• Issue:
  43
• NIOSHTIC Number:
  nn:20057600
• Citation:
  MMWR 2019 Nov; 68(43):985-989
• Email:
  emoritz@cdc.gov
• CAS Registry Number:
  (-)-Nicotine (CAS RN 54-11-5) ; Tetrahydrocannabinol (CAS RN 1972-08-3) ; Tobacco oil (CAS RN 8037-19-2)
• Federal Fiscal Year:
  2020
• Performing Organization:
  Public Health Institute
• Peer Reviewed:
  False
• Start Date:
  20050701
• End Date:
  20260630
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR) National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:72f850f6fefd3a69b238e3d20a1e96476f894c82ae110d83582a61ad31201479b483b9c69b04bbcdfc890db2451a16e17ebd14c6511cc2a6b615b8d31b4f70b8
• Download URL:
  https://stacks.cdc.gov/view/cdc/183319/cdc_183319_DS1.pdf
• File Type:
  [PDF - 260.43 KB ]